Skip to content

Clinical trials

Myocardial Infarction trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myocardial Infarction Clear all

1,959 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200013
200125
200221
200349
200440
200559
200664
200772
200854
200971
201079
201183
201272
201367
201484
201586
201682
201777
201883
201972
202094
202192
202286
202386
202470
202572
202683

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed1,102
Unknown status367
Recruiting183
Terminated102
Active, not recruiting71
Not yet recruiting66
Withdrawn49
Enrolling by invitation14
Suspended3
Temporarily not available1
Available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)64
University of Edinburgh19
Mayo Clinic18
Brigham and Women's Hospital17
AstraZeneca16
Karolinska Institutet16
University College, London16
Assistance Publique - Hôpitaux de Paris14
Assiut University14
Deutsches Herzzentrum Muenchen13

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myocardial Infarction1,959
Coronary Artery Disease302
Cardiovascular Diseases287
Acute Coronary Syndrome236
Stroke231
Myocardial Ischemia187
Heart Failure181
ST Elevation Myocardial Infarction178
Heart Diseases177
Coronary Disease161

Trials

Showing 76 to 100 of 1,959. Each trial links to its page on Pharma Observatory.

1,859 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.